FDA Adverse Event
Injury
Summary report: N
BLT Ø3.3MM NC, SLA® 12MM, TIZR, LOXIM
MDR report key: 16114455
·
Received January 6, 2023
Report
- Report Number
- 0001222315-2023-000346
- Event Type
- Injury
- Date Received
- January 6, 2023
- Date of Event
- November 21, 2022
- Report Date
- January 6, 2023
- Manufacturer
- INSTITUT STRAUMANN AG
- Product Code
- DZE
- UDI-DI
- 07630031706737
- Adverse Event
- Yes
- Report Source
- Distributor report
- Reporter Location
- VA, US
- Reporter Occupation
- DENTIST
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2022-08-01 IN ADA 22. ON (B)(6) 2022, LOSS OF OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 635192 | BLT Ø3.3MM NC, SLA® 12MM, TIZR, LOXIM | ENDOSSEOUS DENTAL IMPLANT | DZE | INSTITUT STRAUMANN AG | SLA Roxolid BL | HWF11 | 07630031706737 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 69 YR | Male | Required Intervention |